Barrington Research reiterated their outperform rating on shares of U.S. Physical Therapy (NYSE:USPH – Free Report) in a report published on Monday morning,Benzinga reports. Barrington Research currently has a $103.00 price target on the stock.
A number of other equities analysts have also issued reports on the company. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Monday, December 15th. Wall Street Zen cut U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Sunday, September 21st. Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. cut their price target on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Monday, November 24th. Four research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and an average target price of $105.33.
Check Out Our Latest Research Report on USPH
U.S. Physical Therapy Stock Performance
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last released its quarterly earnings results on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. The company had revenue of $140.66 million for the quarter. U.S. Physical Therapy had a net margin of 5.71% and a return on equity of 8.62%. Sell-side analysts predict that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Shareholders of record on Monday, November 17th were issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.3%. The ex-dividend date was Monday, November 17th. U.S. Physical Therapy’s payout ratio is presently 75.63%.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the company. Parallel Advisors LLC raised its holdings in shares of U.S. Physical Therapy by 90.6% during the second quarter. Parallel Advisors LLC now owns 448 shares of the company’s stock valued at $35,000 after acquiring an additional 213 shares during the period. Cullen Frost Bankers Inc. raised its stake in U.S. Physical Therapy by 171.8% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock valued at $35,000 after purchasing an additional 280 shares during the period. Advisory Services Network LLC purchased a new stake in shares of U.S. Physical Therapy in the third quarter valued at $39,000. EverSource Wealth Advisors LLC lifted its holdings in shares of U.S. Physical Therapy by 68.8% in the third quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock valued at $40,000 after purchasing an additional 192 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of U.S. Physical Therapy by 207.1% in the fourth quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock worth $40,000 after buying an additional 348 shares during the period.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Recommended Stories
- Five stocks we like better than U.S. Physical Therapy
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
